Objectives: This study aimed to examine the validity and reliability of a Web-based version of the epidemiology of prolapse and incontinence questionnaire (EPIQ).
T he epidemiology of prolapse and incontinence questionnaire (EPIQ) is a self-administered instrument designed to identify prevalence and risk factors for bothersome female pelvic floor disorders (PFDs) in population-based research. 1 The entire questionnaire is a 16-page document that includes demographic, medical, and obstetric history along with 22 stem questions related to urinary and bowel symptom bother as measured on 100mm visual analog scales (VAS). Unlike most condition specific instruments used in pelvic medicine, it was specifically validated in a diverse population of women both seeking as well as not seeking care for PFD. 1 The EPIQ addresses a broad spectrum of symptoms related to pelvic floor, urinary, and bowel function, with reported predictive values for identification of bothersome stress urinary incontinence (SUI), overactive bladder (OAB), anal incontinence (AI), and pelvic organ prolapse (POP).
Although the EPIQ was developed and validated as a selfadministered written instrument, there are limitations to this method of administration in the electronic age. 2 There may be several advantages to completing this type of questionnaire electronically in future research. For example, skip patterns and quality control parameters can be made automatic, data entry errors can be minimized, costs associated with printing, distributing and data entry are obviated, and data are rapidly available. 3 A Web-based entry system is ideal for populationbased studies in which participants do not otherwise need to present to a clinical office for evaluation or form completion.
The Pelvic Floor Distress Inventory (PFDI) and the International Consultation on Incontinence Modular Questionnaire-Lower Urinary Tract Symptoms Quality of Life, instruments that assess pelvic floor symptom burden in individuals presenting for care for PFDs, have established reproducibility when administered by Web and paper. 4, 5 The aims of this study were to examine the stability of constructs, internal consistency, and test-retest reliability of a Web-based version of the EPIQ; and to assess intermethod reliability compared to the standard paperbased administration, in a population of community-dwelling and primary care participants not seeking care for PFDs.
MATERIALS AND METHODS
This study was approved by the University of Utah institutional review board, and all participants signed informed consent. English-speaking participants were recruited from an ongoing case-control study whose aim is to estimate the association between lifetime physical activity and current POP and SUI. 6 Women not seeking care for PFDs were recruited from more than 20 primary care level gynecology and family medicine clinics located across the Salt Lake Valley and from community advertising. The exclusion criteria for the parent study included current pregnancy or within 6 months postpartum, younger than 39 or older than 65 years, body mass index (BMI) less than 18.5 kg/m 2 or greater than or equal to 40 kg/m 2 , history of prior surgical treatment of prolapse or incontinence, predominant urgency incontinence as identified by the 3-IQ, inability to walk independently, major medical problems precluding exercise for the last 12 months, medical conditions associated with incontinence or low physical activity (including diabetes, neurologic disorders such as multiple sclerosis, spinal cord injury, or stroke; rheumatoid arthritis, blindness, radical hysterectomy or pelvic irradiation), currently undergoing treatment of cancer, or unable to complete questionnaires. Of those recruited to the parent study, 19 women had ages or BMI above or below the inclusion cutpoint for the primary study; however, they were included in this EPIQ validation study. All women enrolled by February 2012 who completed at least 1 version of the EPIQ were included in these analyses.
Participants in the parent study were given the option of participating in ancillary studies aimed at evaluating the reproducibility of Web versions of previously validated questionnaires including the lifetime physical activity questionnaire (LPAQ) 7 and the EPIQ. 1 These participants completed the study instruments at home whether once by Web, once by paper, twice by paper, twice by Web, or once by Web and once by paper. Written forms were returned by mail. For those who agreed to complete both Web and paper instruments, the order of administration was randomized to Web versus paper first, by opening sealed opaque envelopes. Women completed the EPIQ only after administration of the LPAQ and the occupation questionnaire 8 from a different historical activity instrument, which resulted in a lengthy battery of questions regarding leisure, household, and outdoor activity over various age epochs. We did not assess time for completion of the series of instruments; however, it was estimated that the LPAQ would take approximately 45 minutes to complete.
The aims of this study were to examine the stability of constructs, internal consistency, and test-retest reliability of the 22 items related to PFD in a Web-based version of the EPIQ. Thus, we first determined whether the same set of domains, or underlying factors, were identified in this population as compared to the original population in which the instrument was validated. This was performed using principal components factor analysis with varimax rotation in SAS 9.3 on the 22 EPIQ items about presence and severity of various symptoms. Factor analysis was based on women who first or solely completed a Web -based version of the EPIQ. When a woman answered negatively about the presence of a symptom, the accompanying VAS response about bother was set to zero as was established in the original validation study. In the original EPIQ validation, the following domains emerged: SUI, OAB, AI, and POP; plus 3 additional factors for which criterion validity could not be established: incontinence-related quality of life, defecatory dysfunction, and pain and difficult voiding. As in the original study, we identified the number of factors with eigenvalues greater than 1.0 and performed varimax rotation to determine whether the original subscales were reproduced for the Web-based version. Factor loadings of at least 0.4 1 were considered meaningful.
Each subscale was then represented by an average of its items for further analysis. We estimated internal consistency of the Web-based version using > coefficients for each subscale, except the POP subscale, which has only 1 item. For women who completed 1 Web-based and 1 paper-based version of the EPIQ, we tested whether the > coefficients differed between the Web-based and paper-based versions. 9 Criterion validity was not assessed in this population as women with PFD were not specifically included and definitions for identifying symptomatic PFD were not consistent with the original EPIQ description. As noted, the goal of the EPIQ is to identify women bothered enough by a PFD to seek treatment; in the original validation study, half of women were recruited from urogynecology clinics (ie, seeking care for a PFD) and half from a general gynecology clinic. In our parent study, we specifically recruited women not seeking care and so would not expect to have the full spectrum of disease needed to assess criterion validity. We assumed that if the Web version was found to be reproducible, maintained the same internal consistency, and loaded on the same factors, there would be no need to reassess criterion validity.
For women who completed 2 Web versions of the EPIQ, we assessed test-retest reliability using intraclass correlation coefficients (ICCs). 10 For women who completed 1 Web-based and 1 paper-based version of the EPIQ, we calculated the intermethod correlation as an ICC for each subscale. We also scrutinized Bland-Altman plots for bias and outliers. 11 The presence or absence of SUI, OAB, AI, and POP was determined using formulas noted in the original validation paper. Demographics and subscales were compared across unmatched study groups by independent samples t tests, Pearson W 2 test, or Fisher exact test, as appropriate; and across the same study group on 2 occasions by paired t tests or McNemar W 2 test. Correlations were considered acceptable if above 0.70. 12 Statistical tests were 2-sided, at the conventional 5% significance level.
A priori sample size calculations estimated that the sample size would be adequate as follows: In the comparison of > coefficients for the Web-versus paper-based EPIQ, 100 women who completed both versions would provide 80% power to detect Feldt C = 1.67, for example, Cronbach > of 0.8 versus Cronbach > of 0.666. 9 Fifty-one women completing the Webbased (or paper-based) EPIQ twice would provide 80% power to detect a single Pearson correlation of 0.8 versus 0.65; and similarly for Web-based versus paper-based comparisons. The final sample size was ultimately limited by constraints of the parent study.
RESULTS
Of the 1093 women enrolled into the parent study at the time of this data analysis, 609 agreed to participate in the testretest component of this study, and 213 were randomized to receive paper-then-Web surveys or Web-then-paper surveys; 384 completed at least 1 Web-based EPIQ survey and 492 at least 1 paper-based EPIQ (384 + 492 = 876, in Fig. 1 ). For those who completed the first survey and agreed to complete a second survey, 276 (55.6%) of 496 (193 + 131 + 172 = 496) did so, including 104 (49%) of the 213 randomized women. Participant flow is summarized in Figure 1 . As noted, withdrawal from the test-retest component of the study was common. This may be in part due to the length of the LPAQ survey studied in tandem with the EPIQ as only 40 women who completed the physical activity survey then failed to complete the EPIQ. Overall, 63 women completed Web twice, 57 Web-then-paper versions, 47 paper-then-Web versions, and 109 completed the paper version twice (Fig. 1) .
Factor analyses of the Web version of EPIQ were based on the 384 women who completed a Web-based EPIQ as the first or only administration. Table 1 shows the baseline characteristics of the women who completed the Web-versus paper-based EPIQ first. Those who completed the second administration of the questionnaires were similar to the larger sample (data not shown). Most women were white (93%), with a mean age of roughly 50 years. Compared to women who completed the paper-based EPIQ first, those who completed the Web-based EPIQ first were slightly younger (50 vs 51 years, P = 0.002), with more education (65% vs 56% with some college, P = 0.001) and had lower parity (21% vs 19% with 0 births, P = 0.019.) The average time between survey completion was approximately 2.5 months, and longer for women who took the paper-based EPIQ first early in the study (P = 0.036.)
Stability of Construct Validity in Web-Based EPIQ
In the present study, factor analyses supported several possible models; however, the 7-factor model was most clinically plausible and closely represented the original EPIQ factors, recognizing that 2 eigenvalues were slightly less than 1.0. This model explained more than 70% of the total variance and other than Given the exclusion criteria set out for the parent study to minimize presence of bothersome UI, these findings were not unexpected. Table 2 displays factor loadings for the Web version of each EPIQ domain along with internal consistency of the clinically relevant subscales: SUI, OAB, AI, and POP for the Web-and paper-based versions. Factor analyses for paper version of EPIQ are not shown, but were not significantly different. Internal consistency was high and comparable to the originally reported instrument regardless of method of administration ( Table 2) . Descriptive statistics for these subscales with mean (SD) VAS scores are demonstrated in Table 3 . Examination of the range of scores reported during Web-based versus paper-based completion of the EPIQ revealed that the minimum score was 0 in every context, but the maximum score for a subscale tended to be slightly higher when reported on paper than when reported via Web. Table 3 also shows that the mean subscale scores were 2 to 6 mm higher for paper completion as compared to Web (P G 0.05 by paired t test for paper-first versus Web-first, except AI). Of note, when administering the Web version of the VAS scale, the default score was set to zero and the subject was required to move the bar from that location to a higher degree of bother, possibly explaining these small differences in mean VAS scores. Bland-Altman plots revealed some outliers, in which a woman reported few symptoms on one occasion and many on the other. The POP scale revealed a very low range of responses in some of the reproducibility subgroups except the paper-paper and Web-paper groups, where responses spanned the entire 0 to 100 mm VAS scale. Thus, reproducibility of the Web version of the EPIQ could not be determined for POP. Table 4 demonstrates acceptable intraclass correlations ranging from 0.68 to 0.91. However, the reproducibility subgroups included too few bothersome POP cases to be evaluated. Table 4 also shows intermethod reliability above 0.8 for SUI, OAB, POP, and paper-based AI, which was similar to the original EPIQ.
Test-Retest and Intermethod Reliability

DISCUSSION
We endorse the use of the Web-based EPIQ to identify bothersome PFDs among women not seeking care for PFDs. Overall, compared to paper administration, Web administration of the EPIQ has similar psychometric properties with comparable internal consistency and test-retest reliability when administered in the same modality. Reliability between both methods of administration is acceptable for SUI, OAB, and AI. Because very few women in the reliability studies had POP (as defined by the EPIQ), reliability of a bothersome POP diagnosis using Web administration cannot be certain; future validation in women with POP should be done to confirm this. Overall, the Web-based administration of the EPIQ survey seems to be a valid method of administration in our population of women not seeking care for PFDs. Lukacz et al 1 initially developed biologically valid definitions of PFDs and determined criterion validity, construct validity, internal consistency, and test-retest reliability of the paper-based EPIQ survey in a Kaiser population of women aged 25 to 84 years, 50% of whom had PFDs with the rest recruited from a general gynecology office. In contrast, our study group was more nearly middle-aged (age, 38Y65 years) and 90% were educated beyond high school, compared to 80% in the Kaiser population. Despite the fact that our study population had less variability in the range of PFDs, the stability of constructs (factors) was still comparable to the original EPIQ study. Only the SUI domain included some urge incontinence questions that loaded preferentially onto the SUI domain. We are not surprised by this finding because women with urge urinary incontinence were specifically excluded from the parent study. Thus, those women with UI may have had stress predominant mixed UI, forcing the responses onto a ''urinary incontinence'' domain as opposed to an OAB one. Further, the fact that the test-retest reliability of the 2 questionnaire completions was good (regardless of method) is reassuring. In fact, our reliability estimates are likely underestimates given the relatively long interadministration interval and the fact that POP and UI are known to wax and wane to some degree over time. 13, 14 Although we found that Web-based EPIQ subscale scores were lower, on average, than paper-based scores, the average variation between the 2 ranged from 2 to 6 mm. We suspect that this difference relates to the way in which people complete VAS. For the Web-based version, the cursor for the VAS is set at zero and women had to manually move it to express bother related to a given symptom greater than none. For the paperbased version, women placed a mark near the zero line to indicate no bother and thus the mark could be several millimeters away from zero. With our large sample size, these differences were statistically significant but not likely clinically relevant (though the minimum clinical important differences for EPIQ subscales have not yet been established). Diagnosing conditions using the EPIQ requires VAS bother scores far greater than the differences seen between versions (eg, 947.3 for SUI, 933 for POP, and 922.8 for AI). 1 Strengths of this study include the rigorous psychometric statistical testing of a large number of subjects completing a Web-based version of previously validated instrument. Limitations of our study include the inability to ascertain criterion validity or discriminant validity due to the nature of the parent study; further, because our population was not seeking care for PFDs, we are not able to provide evidence that actual careseeking behavior varies by Web-based EPIQ scores. The study is also limited by the large withdrawal rate between the first and second questionnaire administration. Although there were statistically significant differences in some demographic variables between women that withdrew and women that completed the reproducibility study, these differences (such as a several month difference in age) were not clinically meaningful and are unlikely to have biased our results. As noted previously, we suspect the high withdrawal rate is due to the long physical activity questionnaire that preceded the EPIQ; very few women completed the former but not the EPIQ. Among completers, women who first completed the Web-based EPIQ were slightly younger, more educated, and with lower parity than women who first completed a paper-based EPIQ, and their time interval between surveys was shorter. It is unlikely that these differences altered the internal validity of the test-retest and intermethod comparison, because we used an intraclass correlation which penalized for differences between groups. 10 Therefore, the adequate to high reliabilities found in this study had to overcome any differences among groups and are thus conservative. Women were allowed to choose whether to complete the paper version twice, the Web version twice, or each version once. It is likely that more experienced Web users chose to do the Web version; thus, we do not know whether our results would hold for less experienced Web users. However, Internet use continues to rise and as of April 2012, 91%, 77%, and 53% of Americans between ages 30 to 49, 50 to 64, and 65 years or older, respectively, reported using the Internet at least occasionally and thus would be able to complete the Web version. 15 Finally, because women older than 65 years were excluded from the parent study, we also do not know whether our results hold for older women; given the older age of many women with PFDs, future work confirming the acceptability of Web-based instruments in this population is needed.
The EPIQ now joins the PFDI and the International Consultation on Incontinence Modular Questionnaire-Lower Urinary Tract Symptoms Quality of Life, as tools to assess PFDs with proven reproducibility when administered by Web and paper. 4, 5 In contrast to the PFDI, which was validated in women with PFDs, the EPIQ adds value to community-based research targeting women not presenting for care. This study establishes internal consistency, test-retest reliability, and intermethod reliability of the Web-based version of the EPIQ survey, among women in primary are and the community, aged 38 to 65 years, not seeking care for PFDs.
